SCHEMBL1951320

SCHEMBL1951320

CC1(Cc2cncnc2)C(=O)NCc2ccc(-c3cccc(OC(F)(F)F)c3)cc21

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SCN9A Q15858 3/20 0.38
▸ GRIN1 Q05586 2/20 0.38
▸ GRIN2B Q13224 2/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ BACE1 P56817 3/20 0.37
▸ XDH P47989 1/20 0.37
▸ CTSD P07339 1/20 0.37
▸ BACE2 Q9Y5Z0 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950045 0.89 BACE1 (0.39) GRIN1GRIN2BEPHX2BACE1
SCHEMBL1950191 0.87 EPHX2 (0.43) OTUD7BGRIN1GRIN2BEPHX2
SCHEMBL1951020 0.87 OTUD7B (0.40) OTUD7BSCN9AGRIN1GRIN2BBACE1
SCHEMBL3016588 0.86 PGR (0.51) OTUD7BEPHX2
SCHEMBL1949290 0.86 GRIN1 (0.43) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1852299 0.85 EPHX2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1849671 0.85 GRIN1 (0.39) OTUD7BCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1949697 0.80 OTUD7B (0.38) OTUD7BSCN9ABACE1XDHABL1
SCHEMBL1949443 0.78 CACNA1B (0.42) GRIN1GRIN2BEPHX2
SCHEMBL2805793 0.76 GRIN1 (0.38) OTUD7BCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US claimed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers CACNA1D, TRPV1, CACNA1S OTUD7B 592/4885CYP1A2 1049/4885CYP3A4 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback